Page last updated: 2024-10-22

amitriptyline and Arthritis, Juvenile Chronic

amitriptyline has been researched along with Arthritis, Juvenile Chronic in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huber, AM1
Tomlinson, GA1
Koren, G1
Feldman, BM1

Trials

1 trial available for amitriptyline and Arthritis, Juvenile Chronic

ArticleYear
Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials.
    The Journal of rheumatology, 2007, Volume: 34, Issue:5

    Topics: Adolescent; Amitriptyline; Analgesics, Non-Narcotic; Arthritis, Juvenile; Bayes Theorem; Child; Dose

2007